Market Size & Growth Forecast
The global veterinary vaccines market is on a strong growth trajectory, underpinned by rising awareness of animal health, expanded pet ownership, and heightened focus on preventive care. According to MarketsandMarkets™, the market size is expected to grow from approximately US$11.63 billion in 2025 to around US$16.15 billion by 2030, registering a compound annual growth rate (CAGR) of 6.8% during the forecast period (2025–2030).
Key Segmentation & Trends
1. Market by Type
-
Livestock vaccines represent the largest segment of the animal vaccines market, reflecting the critical need for immunization in production animals to ensure food security and reduce disease-related losses.
2. Market by Technology
-
Live attenuated vaccines hold the most significant share of the market, driven by their effectiveness in generating strong immune responses and broad disease protection in multiple animal species.
3. Route of Administration
-
The subcutaneous route accounts for the largest share of vaccine administration, widely preferred for ease of use and reliable immune response in both livestock and companion animals.
4. End Users
-
Veterinary hospitals and clinics remain the dominant distribution channels, providing immunization services across companion animals, livestock, and poultry.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1233
Regional Dynamics
-
Asia Pacific is highlighted as the fastest-growing region in the veterinary vaccines market during the forecast period. Rapidly increasing disposable incomes, expanding middle classes, and rising pet ownership in countries such as China and India are key drivers of market growth in this region.
-
North America and Europe continue to hold substantial shares due to well-established veterinary care infrastructure, high pet insurance adoption, and strong disease prevention programs.
Market Drivers
Several factors are supporting growth in the animal vaccines sector:
-
Rising Pet Ownership & Preventive Care Demand: Greater spending on companion animal health, including vaccinations, is bolstering market expansion.
-
Prevention of Zoonotic Diseases: Increased emphasis on preventing diseases that can transfer from animals to humans is driving vaccine adoption in both developed and emerging economies.
-
Government Initiatives & Animal Health Programs: Public sector efforts aimed at enhancing animal welfare, improving livestock productivity, and ensuring food safety contribute significantly to market momentum.
-
Innovation & Technology Advancements: Development of novel vaccines, such as recombinant and DNA-based platforms, coupled with efficient cold-chain logistics, is enhancing immunization efficiency and broadening protection coverage.
Competitive Landscape
The industry is led by global and regional players with robust product portfolios, strong R&D capabilities, and extensive distribution networks. Key market participants include:
-
Zoetis
-
Merck & Co., Inc.
-
Boehringer Ingelheim International GmbH
-
Elanco
-
Virbac
-
Ceva
-
Hester Biosciences Limited
-
Neogen Corporation
-
HIPRA
-
Biogénesis Bagó
These companies are investing in expanding manufacturing capacities, new vaccine formulations, and strategic collaborations to capitalize on the growing demand for animal immunization products.
Strategic Insights
-
The shift toward advanced vaccine technologies and delivery systems is reshaping the market’s competitive landscape.
-
Growing awareness of the economic value of preventing diseases in livestock and pets is elevating immunization programs across regions.
-
Emerging economies present significant untapped potential due to increasing livestock populations, rising incomes, and enhanced veterinary healthcare accessibility.
In summary, the animal vaccines market is positioned for steady, resilient growth through 2030, driven by preventive healthcare trends, technological innovation, expanded regional demand, and strategic industry investment.
Request Sample Pages@ https://www.marketsandmarkets.com/requestsampleNew.asp?id=1233